Severe Acute Pulmonary Toxicity Associated with Brentuximab in a Patient with Refractory Hodgkin’s Lymphoma

<div>(a) Computed tomography (CT) of the chest showing patchy, nodular ground glass opacities along a bronchovascular distribution throughout both lungs. (b) CT of the chest showing resolution of previously seen opacities after discontinuation.</div>

Case Reports in Pulmonology

fig1

Figure 1

Figure 1: Severe Acute Pulmonary Toxicity Associated with Brentuximab in a Patient with Refractory Hodgkin’s Lymphoma 